Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


Articles published in Clin Chem

Retrieve available abstracts of 56 articles:
HTML format
Text format



Single Articles


    April 2017
  1. KAVSAK PA, Clark L, Jaffe AS
    Effect of Repeat Measurements of High-Sensitivity Cardiac Troponin on the Same Sample Using the European Society of Cardiology 0-Hour/1-Hour or 2-Hour Algorithms for Early Rule-Out and Rule-In for Myocardial Infarction.
    Clin Chem. 2017 Apr 20. pii: clinchem.2017.272914.
    PubMed     Text format    


    March 2017
  2. DIEPLINGER B, Bocksrucker C, Egger M, Eggers C, et al
    Prognostic Value of Inflammatory and Cardiovascular Biomarkers for Prediction of 90-Day All-Cause Mortality after Acute Ischemic Stroke-Results from the Linz Stroke Unit Study.
    Clin Chem. 2017 Mar 27. pii: clinchem.2016.269969.
    PubMed     Text format     Abstract available


  3. CLERICO A, Passino C
    Predictive Value of NT-proBNP in Patients with Acute Myocardial Infarction.
    Clin Chem. 2017 Mar 20. pii: clinchem.2016.269522.
    PubMed     Text format    


    January 2017
  4. MINGELS AM, Cardinaels EP, Broers NJ, van Sleeuwen A, et al
    Cardiac Troponin T: Smaller Molecules in Patients with End-Stage Renal Disease than after Onset of Acute Myocardial Infarction.
    Clin Chem. 2017 Jan 10. pii: clinchem.2016.261644.
    PubMed     Text format     Abstract available


  5. BREITLING LP, Mons U, Hahmann H, Koenig W, et al
    The Longer, the Better? An Empirical Study of the Extent and Mechanisms of Attenuating Biomarker Associations in Cardiovascular Patient Cohorts.
    Clin Chem. 2017 Jan 10. pii: clinchem.2016.263202.
    PubMed     Text format     Abstract available


  6. BODOR GS
    Does This Patient Have Acute Myocardial Infarction?
    Clin Chem. 2017;63:439-440.
    PubMed     Text format    


  7. SUZUKI T, Heaney LM, Jones DJ, Ng LL, et al
    Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction.
    Clin Chem. 2017;63:420-428.
    PubMed     Text format     Abstract available


  8. SHORTT C, Ma J, Clayton N, Sherbino J, et al
    Rule-In and Rule-Out of Myocardial Infarction Using Cardiac Troponin and Glycemic Biomarkers in Patients with Symptoms Suggestive of Acute Coronary Syndrome.
    Clin Chem. 2017;63:403-414.
    PubMed     Text format     Abstract available


  9. PRICKETT TC, Doughty RN, Troughton RW, Frampton CM, et al
    C-Type Natriuretic Peptides in Coronary Disease.
    Clin Chem. 2017;63:316-324.
    PubMed     Text format     Abstract available


  10. CULLEN LA, Mills NL, Mahler S, Body R, et al
    Early Rule-Out and Rule-In Strategies for Myocardial Infarction.
    Clin Chem. 2017;63:129-139.
    PubMed     Text format     Abstract available


  11. SANDOVAL Y, Thygesen K
    Myocardial Infarction Type 2 and Myocardial Injury.
    Clin Chem. 2017;63:101-107.
    PubMed     Text format     Abstract available


  12. TRICOCI P
    Consensus or Controversy?: Evolution of Criteria for Myocardial Infarction After Percutaneous Coronary Intervention.
    Clin Chem. 2017;63:82-90.
    PubMed     Text format     Abstract available


  13. HUGHES MF, Ojeda F, Saarela O, Jorgensen T, et al
    Association of Repeatedly Measured High-Sensitivity-Assayed Troponin I with Cardiovascular Disease Events in a General Population from the MORGAM/BiomarCaRE Study.
    Clin Chem. 2017;63:334-342.
    PubMed     Text format     Abstract available


  14. ABBASI A, Kieneker LM, Corpeleijn E, Gansevoort RT, et al
    Plasma N-terminal Prosomatostatin and Risk of Incident Cardiovascular Disease and All-Cause Mortality in a Prospective Observational Cohort: the PREVEND Study.
    Clin Chem. 2017;63:278-287.
    PubMed     Text format     Abstract available


  15. EGGERS KM, Lindahl B
    Application of Cardiac Troponin in Cardiovascular Diseases Other Than Acute Coronary Syndrome.
    Clin Chem. 2017;63:223-235.
    PubMed     Text format     Abstract available


  16. WOLLERT KC, Kempf T, Wallentin L
    Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease.
    Clin Chem. 2017;63:140-151.
    PubMed     Text format     Abstract available


  17. MAHLEY RW
    Apolipoprotein E: Remarkable Protein Sheds Light on Cardiovascular and Neurological Diseases.
    Clin Chem. 2017;63:14-20.
    PubMed     Text format    


  18. APPLE FS, Cullen L, Felker GM, Ginsburg G, et al
    Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics.
    Clin Chem. 2017;63:1-4.
    PubMed     Text format    


    December 2016
  19. WU Z, Huang Z, Jin W, Rimm EB, et al
    Peripheral Inflammatory Biomarkers for Myocardial Infarction Risk: A Prospective Community-Based Study.
    Clin Chem. 2016 Dec 28. pii: clinchem.2016.260828.
    PubMed     Text format     Abstract available


  20. KVISVIK B, Morkrid L, Rosjo H, Cvancarova M, et al
    High-Sensitivity Troponin T vs I in Acute Coronary Syndrome: Prediction of Significant Coronary Lesions and Long-term Prognosis.
    Clin Chem. 2016 Dec 14. pii: clinchem.2016.261107.
    PubMed     Text format     Abstract available


  21. STRENG AS, de Boer D, van Doorn WP, Bouwman FG, et al
    Identification and Characterization of Cardiac Troponin T Fragments in Serum of Patients Suffering from Acute Myocardial Infarction.
    Clin Chem. 2016 Dec 9. pii: clinchem.2016.261511.
    PubMed     Text format     Abstract available


  22. CAPPELLETTI P, Morandini M, Moretti M, Malloggi L, et al
    How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction? The Italian Experience.
    Clin Chem. 2016 Dec 9. pii: clinchem.2016.266429.
    PubMed     Text format    


  23. MUELLER-HENNESSEN M, Mueller C, Giannitsis E, Biener M, et al
    Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation.
    Clin Chem. 2016 Dec 8. pii: clinchem.2016.258392.
    PubMed     Text format     Abstract available


  24. LINDHOLM D, James SK, Bertilsson M, Becker RC, et al
    Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
    Clin Chem. 2016 Dec 8. pii: clinchem.2016.261271.
    PubMed     Text format     Abstract available


    November 2016
  25. NEUMANN JT, Sorensen NA, Ojeda F, Schwemer T, et al
    Immediate Rule-out of Acute Myocardial Infarction Using Electrocardiogram and Baseline High-Sensitivity Troponin I.
    Clin Chem. 2016 Nov 30. pii: clinchem.2016.262659.
    PubMed     Text format     Abstract available


  26. EVERETT BM, Ridker PM
    Biomarkers for Cardiovascular Screening: Progress or Passe?
    Clin Chem. 2016 Nov 30. pii: clinchem.2016.254854.
    PubMed     Text format    


  27. NEWBY LK
    Reconciling Systems for Acute Myocardial Infarction Definition and Coding Classification.
    Clin Chem. 2016 Nov 18. pii: clinchem.2016.266999.
    PubMed     Text format    


  28. TUNIS SR, Messner DA
    Payer Perspectives on Coverage of Biomarker Testing in Cardiovascular Disease.
    Clin Chem. 2016 Nov 18. pii: clinchem.2016.268136.
    PubMed     Text format    


  29. FRIEDE K, Li J, Voora D
    Use of Pharmacogenetic Information in the Treatment of Cardiovascular Disease.
    Clin Chem. 2016 Nov 18. pii: clinchem.2016.255232.
    PubMed     Text format     Abstract available


  30. OMLAND T, White HD
    State of the Art: Blood Biomarkers for Risk Stratification in Patients with Stable Ischemic Heart Disease.
    Clin Chem. 2016 Nov 4. pii: clinchem.2016.255190.
    PubMed     Text format     Abstract available


  31. SMALL AM, Mehta NN, Rader DJ
    The Role of Emerging Biomarkers in Unraveling the Complex Biology Underlying Associations between HDL Cholesterol and Cardiovascular Diseases.
    Clin Chem. 2016 Nov 4. pii: clinchem.2016.267922.
    PubMed     Text format    


  32. DIAZ-GARZON J, Sandoval Y, Smith SW, Love S, et al
    Discordance between ICD-Coded Myocardial Infarction and Diagnosis according to the Universal Definition of Myocardial Infarction.
    Clin Chem. 2016 Nov 3. pii: clinchem.2016.263764.
    PubMed     Text format     Abstract available


  33. SHORTT C, Xie F, Whitlock R, Ma J, et al
    Economic Considerations of Early Rule-In/Rule-Out Algorithms for The Diagnosis of Myocardial Infarction in The Emergency Department Using Cardiac Troponin and Glycemic Biomarkers.
    Clin Chem. 2016 Nov 3. pii: clinchem.2016.261776.
    PubMed     Text format     Abstract available


  34. OHMAN EM
    Redefining the Gold Standard of Myocardial Infarction Using Troponin T.
    Clin Chem. 2016 Nov 3. pii: clinchem.2016.267047.
    PubMed     Text format    


  35. HAGSTROM E, Held C, Stewart RA, Aylward PE, et al
    Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease.
    Clin Chem. 2016 Nov 3. pii: clinchem.2016.260570.
    PubMed     Text format     Abstract available


  36. MCGARRAH RW, Kelly JP, Craig DM, Haynes C, et al
    A Novel Protein Glycan-Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality.
    Clin Chem. 2016 Nov 3. pii: clinchem.2016.261636.
    PubMed     Text format     Abstract available


    October 2016
  37. KLINKENBERG LJ, Wildi K, van der Linden N, Kouw IW, et al
    Diurnal Rhythm of Cardiac Troponin: Consequences for the Diagnosis of Acute Myocardial Infarction.
    Clin Chem. 2016 Oct 5. pii: clinchem.2016.257485.
    PubMed     Text format     Abstract available


    August 2016
  38. JANSEN H, Koenig W, Jaensch A, Mons U, et al
    Prognostic Utility of Galectin-3 for Recurrent Cardiovascular Events During Long-term Follow-up in Patients with Stable Coronary Heart Disease: Results of the KAROLA Study.
    Clin Chem. 2016 Aug 18. pii: clinchem.2016.257550.
    PubMed     Text format     Abstract available


    July 2016
  39. COLLINSON P, Hammerer-Lercher A, Suvisaari J, Apple FS, et al
    How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction: The CARdiac MArker Guidelines Uptake in Europe Study (CARMAGUE).
    Clin Chem. 2016 Jul 26. pii: clinchem.2016.259515.
    PubMed     Text format     Abstract available


  40. LAWLER PR, Everett BM
    Assessing the Effects of Diet and Behavior on Cardiovascular Disease: The Role of Biomarkers in Understanding Biology and Mechanism.
    Clin Chem. 2016 Jul 18. pii: clinchem.2016.260448.
    PubMed     Text format    


    June 2016
  41. KAIER TE, Anand A, Shah AS, Mills NL, et al
    Temporal Relationship between Cardiac Myosin Binding Protein C and Cardiac Troponin I in Type 1 Myocardial Infarction.
    Clin Chem. 2016 Jun 20. pii: clinchem.2016.257188.
    PubMed     Text format    


  42. SCHELLER MADRID A, Rode L, Nordestgaard BG, Bojesen SE, et al
    Short Telomere Length and Ischemic Heart Disease: Observational and Genetic Studies in 290 022 Individuals.
    Clin Chem. 2016 Jun 3. pii: clinchem.2016.258566.
    PubMed     Text format     Abstract available


    May 2016
  43. DALLMEIER D, Brenner H, Mons U, Rottbauer W, et al
    Growth Differentiation Factor 15, Its 12-Month Relative Change, and Risk of Cardiovascular Events and Total Mortality in Patients with Stable Coronary Heart Disease: 10-Year Follow-up of the KAROLA Study.
    Clin Chem. 2016 May 19. pii: clinchem.2016.254755.
    PubMed     Text format     Abstract available


  44. DUPREZ DA, Otvos J, Sanchez OA, Mackey RH, et al
    Comparison of the Predictive Value of GlycA and Other Biomarkers of Inflammation for Total Death, Incident Cardiovascular Events, Noncardiovascular and Noncancer Inflammatory-Related Events, and Total Cancer Events.
    Clin Chem. 2016 May 12. pii: clinchem.2016.255828.
    PubMed     Text format     Abstract available


    April 2016
  45. KAVSAK PA, Don-Wauchope AC, Hill SA, Worster A, et al
    Acceptable Analytical Variation May Exceed High-Sensitivity Cardiac Troponin I Cutoffs in Early Rule-Out and Rule-In Acute Myocardial Infarction Algorithms.
    Clin Chem. 2016 Apr 26. pii: clinchem.2016.255448.
    PubMed     Text format    


  46. TRAMBAS C, Pickering JW, Than M, Bain C, et al
    Impact of High-Sensitivity Troponin I Testing with Sex-Specific Cutoffs on the Diagnosis of Acute Myocardial Infarction.
    Clin Chem. 2016 Apr 26. pii: clinchem.2015.252569.
    PubMed     Text format     Abstract available


    March 2016
  47. THORSTEINSDOTTIR I, Aspelund T, Gudmundsson E, Eiriksdottir G, et al
    High-Sensitivity Cardiac Troponin I is a Strong Predictor of Cardiovascular Events and Mortality in the AGES-Reykjavik Community Based Cohort of Older Individuals.
    Clin Chem. 2016 Mar 2. pii: clinchem.2015.250811.
    PubMed     Text format     Abstract available


    February 2016
  48. JEPSEN AK, Langsted A, Varbo A, Bang LE, et al
    Increased Remnant Cholesterol Explains Part of Residual Risk of All-Cause Mortality in 5414 Patients with Ischemic Heart Disease.
    Clin Chem. 2016 Feb 17. pii: clinchem.2015.253757.
    PubMed     Text format     Abstract available


  49. RUIZ-CANELA M, Toledo E, Clish CB, Hruby A, et al
    Plasma Branched-Chain Amino Acids and Incident Cardiovascular Disease in the PREDIMED Trial.
    Clin Chem. 2016 Feb 17. pii: clinchem.2015.251710.
    PubMed     Text format     Abstract available


  50. FERGUSON JF, Wang TJ
    Branched-Chain Amino Acids and Cardiovascular Disease: Does Diet Matter?
    Clin Chem. 2016 Feb 16. pii: clinchem.2016.254318.
    PubMed     Text format    


  51. STANCEL N, Chen CC, Ke LY, Chu CS, et al
    Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.
    Clin Chem. 2016;62:320-7.
    PubMed     Text format     Abstract available


    January 2016
  52. BOEDDINGHAUS J, Reichlin T, Cullen L, Greenslade JH, et al
    Two-Hour Algorithm for Triage Towards Rule-Out and Rule-In of Acute Myocardial Infarction by Use of High-Sensitivity Cardiac Troponin I.
    Clin Chem. 2016 Jan 21. pii: clinchem.2015.249508.
    PubMed     Text format     Abstract available


  53. EGGERS KM, Kempf T, Larsson A, Lindahl B, et al
    Evaluation of Temporal Changes in Cardiovascular Biomarker Concentrations Improves Risk Prediction in an Elderly Population from the Community.
    Clin Chem. 2016 Jan 14. pii: clinchem.2015.246876.
    PubMed     Text format     Abstract available


    December 2015
  54. PARIKH RH, Seliger SL, de Lemos J, Nambi V, et al
    Prognostic Significance of High-Sensitivity Cardiac Troponin T Concentrations between the Limit of Blank and Limit of Detection in Community-Dwelling Adults: A Metaanalysis.
    Clin Chem. 2015;61:1524-31.
    PubMed     Text format     Abstract available


    October 2015
  55. SEDAGHAT-HAMEDANI F, Kayvanpour E, Frankenstein L, Mereles D, et al
    Biomarker changes after strenuous exercise can mimic pulmonary embolism and cardiac injury--a metaanalysis of 45 studies.
    Clin Chem. 2015;61:1246-55.
    PubMed     Text format     Abstract available


    September 2015
  56. KAVSAK PA, Pardhan A, Krizmanich W, Worster A, et al
    Hospital Admission and Myocardial Injury Prevalence after the Clinical Introduction of a High-Sensitivity Cardiac Troponin I Assay.
    Clin Chem. 2015;61:1209-10.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: